Solu-Medrol

Stevens-Johnson Syndrome, Pemphigus, Ophthalmia, Sympathetic + 45 more

Treatment

4 FDA approvals

20 Active Studies for Solu-Medrol

Treatment for

Stevens-Johnson Syndrome

What is Solu-Medrol

Methylprednisolone hemisuccinateThe Generic name of this drug

Treatment SummaryMethylprednisolone is a type of steroid medication that is more powerful than prednisone. It was approved by the FDA in 1957 and is currently being studied as a potential treatment for COVID-19-associated pneumonia in those with weakened immune systems. Clinical trials are underway to determine the efficacy of methylprednisolone in treating this virus.

Solu-medrolis the brand name

image of different drug pills on a surface

Solu-Medrol Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Solu-medrol

Methylprednisolone hemisuccinate

1959

89

Approved as Treatment by the FDA

Methylprednisolone hemisuccinate, also known as Solu-medrol, is approved by the FDA for 4 uses including fulminating Pulmonary Tuberculosis and Tuberculous Meningitis .

fulminating Pulmonary Tuberculosis

Used to treat fulminating Pulmonary Tuberculosis in combination with null

Tuberculous Meningitis

Used to treat Tuberculous Meningitis in combination with null

disseminated Pulmonary Tuberculosis (TB)

Used to treat disseminated Pulmonary Tuberculosis (TB) in combination with null

Subarachnoid Block

Used to treat Subarachnoid Block in combination with null

Effectiveness

How Solu-Medrol Affects PatientsCorticosteroids help reduce inflammation by binding to the glucocorticoid receptor. They are often given in doses that are much higher than what the body would normally produce. Taking corticosteroids can lead to a decreased ability to fight off infections and other issues, so it's important to be aware of these risks before starting treatment.

How Solu-Medrol works in the bodyCorticosteroids help reduce swelling and inflammation in the body. They do this by changing gene expression, preventing white blood cells from moving to sites of inflammation, and reducing the production of substances that cause inflammation. Lower doses are anti-inflammatory, while higher doses are immunosuppressive. Long-term, high doses of corticosteroids can raise sodium levels and lower potassium levels.

When to interrupt dosage

The recommended dosage of Solu-Medrol is contingent upon the identified condition, including Inflammation, Necrobiosis lipoidica diabeticorum and Diuresis. The dosage quantity oscillates, commensurate with the administration technique outlined in the table beneath.

Condition

Dosage

Administration

Dermatomyositis (DM)

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Dermatitis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Stevens-Johnson Syndrome

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Ophthalmia, Sympathetic

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Eosinophilic Pneumonia

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Acute Coryza

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Craniotomy

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Metastatic Brain Tumors

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Leukemias

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Congenital Hypoplastic Anemia

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Crohn Disease

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Ankylosing Spondylitis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Subarachnoid Block

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

fulminating Pulmonary Tuberculosis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Hypersensitivity

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Brain

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Palliative Treatment

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Berylliosis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Multiple Sclerosis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Polymyositis

, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg

, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous

Warnings

Solu-Medrol Contraindications

Condition

Risk Level

Notes

intrathecal administration

Do Not Combine

Mycoses

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Methylprednisolone Hemisuccinate may interact with Pulse Frequency

There are 20 known major drug interactions with Solu-Medrol.

Common Solu-Medrol Drug Interactions

Drug Name

Risk Level

Description

Aldesleukin

Major

The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.

Corticorelin ovine triflutate

Major

The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone hemisuccinate.

Macimorelin

Major

The therapeutic efficacy of Macimorelin can be decreased when used in combination with Methylprednisolone hemisuccinate.

1,10-Phenanthroline

Minor

The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Methylprednisolone hemisuccinate.

Aceclofenac

Minor

The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Aceclofenac.

Solu-Medrol Toxicity & Overdose RiskThe toxic dose of glucocorticoids in rats is more than 4g/kg. In mice, the toxic dose is 2292mg/kg, and in rats it is 100mg/kg. If a person takes a large amount of glucocorticoids chronically, they may experience cataracts, glaucoma, high blood pressure, water retention, high cholesterol, ulcers, pancreatitis, muscle weakness, mood changes, psychosis, thinning skin, allergies, acne, increased body hair, lowered immunity, moon face, high blood sugar, low calcium or phosphate levels, acidosis, stunted growth,

image of a doctor in a lab doing drug, clinical research

Solu-Medrol Novel Uses: Which Conditions Have a Clinical Trial Featuring Solu-Medrol?

594 active clinical trials are currently examining the potential of Solu-Medrol to mitigate Asthma, Atopic Dermatitis and Ulcerative Colitis.

Condition

Clinical Trials

Trial Phases

Secondary thrombocytopenia

0 Actively Recruiting

Berylliosis

0 Actively Recruiting

Addison Disease

0 Actively Recruiting

Craniotomy

1 Actively Recruiting

Phase 2

Eosinophilic Pneumonia

0 Actively Recruiting

exfoliative erythroderma

0 Actively Recruiting

Metastatic Brain Tumors

59 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 3, Phase 4

Sarcoidosis

0 Actively Recruiting

Lupus

63 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 3, Phase 4, Early Phase 1

Diuresis

0 Actively Recruiting

Malignant Neoplasms

0 Actively Recruiting

Stevens-Johnson Syndrome

1 Actively Recruiting

Phase 3

Polymyositis

3 Actively Recruiting

Phase 2, Phase 3

Lupus Erythematosus

4 Actively Recruiting

Phase 4, Not Applicable, Phase 1

Palliative Treatment

0 Actively Recruiting

Arthritis, Gouty

0 Actively Recruiting

Malignant Lymphomas

3 Actively Recruiting

Phase 1

induction of Diuresis

0 Actively Recruiting

Thyroiditis

0 Actively Recruiting

Leukemias

0 Actively Recruiting

Solu-Medrol Reviews: What are patients saying about Solu-Medrol?

5Patient Review

8/21/2013

Solu-Medrol for Rheumatoid Arthritis

Solumedral has been an absolute wonder drug for me. I was experiencing debilitating side effects from Taxol and Carbo Platin, but this medication (along with a few others) have almost completely alleviated them.

5Patient Review

4/18/2013

Solu-Medrol for Allergic Reaction caused by a Drug

I didn't notice any difference.

4.7Patient Review

1/17/2014

Solu-Medrol for Multiple Sclerosis

I had an allergic reaction and used my EpiPen. I went to the ER and they gave me IV Benadryl and Solu-Medrol. The Solu-Medrol made me so anxious that I had tachycardia. I felt awful. I was stuck in the ER for 5 hours until the tachycardia subsided.

4.7Patient Review

4/2/2017

Solu-Medrol for Eye Disorder

I experienced some serious side effects while using this medication, but it was effective in reducing the inflammation in my eyes. I no longer have double vision and have recovered most of the mobility in my eyes.

4.3Patient Review

8/20/2014

Solu-Medrol for Multiple Sclerosis

It's easy for me to administer this treatment; the home health nurse starts it when I receive the first dose. I have a port because I have another blood condition which requires monthly IV infusions. This isn't my first time dealing with this, so I'm familiar with the process and not too worried. My blood pressure is going up, but that might just be because I'm in severe pain right now.

4.3Patient Review

9/12/2013

Solu-Medrol for Allergic Reaction caused by a Drug

The only issue I had was that it made it difficult for me to sleep; other than that, great results.

4Patient Review

7/11/2014

Solu-Medrol for Multiple Sclerosis

The monthly IV treatment for my Dermatomyositis has allowed me to walk without stumbling or falling. I'm grateful that we found this option, as it is less invasive than other options (e.g. daily steroid prescriptions) and the positive effects last for almost a month.

4Patient Review

11/6/2012

Solu-Medrol for Joint Disease which may include Attacks of Acute Arthritis

Though the treatments themselves were easy enough, I've been struggling with some nasty side effects like low blood pressure, weakness and fatigue. I'm just hoping these will pass soon.

4Patient Review

5/9/2013

Solu-Medrol for Multiple Sclerosis

I have Familial Mediterranean Fever and this medication really helps me a lot when I need to stop a flare-up. The side effects can be intense for me, but the results are worth it.

4Patient Review

12/21/2016

Solu-Medrol for Eye Disorder

This solumedrol really helped with the inflammation in my eye that prednisone couldn't touch. The swelling is gone now, but my vision is still a bit impaired. The only other downside was a headache and slightly higher blood pressure, but those were manageable.

3.7Patient Review

9/4/2015

Solu-Medrol for Acute Exacerbation of Multiple Sclerosis

I had this infusion done through a port and it was very effective. I only experienced some soreness in my tongue and throat, which may or may not be related to the treatment.

3.7Patient Review

8/5/2015

Solu-Medrol for Multiple Sclerosis

I experienced some soreness, gastrointestinal issues, and my tongue felt raw after taking this medication.

2.7Patient Review

7/29/2012

Solu-Medrol for Multiple Sclerosis

2Patient Review

11/3/2012

Solu-Medrol for Multiple Sclerosis

1.3Patient Review

11/25/2016

Solu-Medrol for Thyroid Gland Inflammation

My face swells up easily. I can't eat yogurt.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about solu-medrol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does Solu-Medrol take to work?

"The medicine will have an effect 6 to 48 hours after it is injected into a muscle. Its effect will be noticeable sooner if it is injected into a vein."

Answered by AI

Is Solu-Medrol the same as prednisone?

"A lower dosage of methylprednisolone is used because it is slightly stronger than prednisone."

Answered by AI

What is Solu-Medrol used for?

"This medication can help to relieve symptoms associated with different medical conditions, including arthritis, blood disorders, severe allergies, certain types of cancer, eye conditions, and skin, kidney, intestinal, and lung diseases. It can also be used to help improve the function of the immune system."

Answered by AI

Is Solu-Medrol a steroid?

"The drug also acts as an immunosuppressant, and is used in the preventative treatment of organ transplantation.

Solu-Medrol is a man-made steroid. It is used to treat severe allergies, skin diseases, hormone disorders, gut diseases, and joint diseases. It also suppresses the immune system, and is used to prevent organ transplant rejection."

Answered by AI

Clinical Trials for Solu-Medrol

Image of Oregon Health & Science University in Portland, United States.

RAY121 for Dermatomyositis

This trial will test the safety and effectiveness of a drug called RAY121 in patients with immune-related diseases such as APS, BP, BS, DM, IMNM, and ITP. The trial

Waitlist Available

Oregon Health & Science UniversitySponsor Chugai Pharmaceutical Co.LtdChugai Pharmaceutical

Image of Mayo Clinic in Rochester, United States.

Patients with Pouchitis for Ulcerative Colitis

This trial investigates the use of intestinal ultrasound (IUS) in evaluating inflammatory bowel disease (IBD), specifically ulcerative colitis (UC) patients with an ileal pouch-anal anastom

Waitlist Available

Mayo ClinicDarrell Pardi, MD

Image of University of Minnesota Medical School in Minneapolis, United States.

FT819 for Lupus

Minneapolis, MN

This trial will test a new drug, FT819, in participants with moderate to severe lupus. The study will first determine the safety and effects of different doses of the drug, followed by a larger

University of Minnesota Medical School (+1 Sites)Fate Therapeutics

Image of Swedish Medical Center in Seattle, United States.

SC291 for Microscopic Polyangiitis

This trial is testing a new drug called SC291 to see if it is safe and well-tolerated in people with severe autoimmune diseases. The study will also look at how the drug affects the body

Swedish Medical CenterPaul BrunettaSana Biotechnology

Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.

Explore trials for Solu-Medrol

Image of Ferring Investigational Site in North Little Rock, United States.

FE 999322 +1 More for Ulcerative Colitis

North Little Rock, AR

"This trial aims to test the safety of two different microbiota treatments compared to a placebo in people with mild to moderate ulcerative colitis."

No Cost For Treatment

Ferring Investigational Site (+2 Sites)Global Clinical ComplianceFerring Pharmaceuticals

Image of Atlantic Medical Research /ID# 258507 in Margate, United States.

Lutikizumab for Ulcerative Colitis

"This trial is testing a new drug called lutikizumab for treating ulcerative colitis (UC) by comparing it to an existing drug called adalimumab. Participants will be divided into

Atlantic Medical Research /ID# 258507 (+8 Sites)ABBVIE INC.AbbVie

Image of National Institutes of Health Clinical Center in Bethesda, United States.

Gusacitinib for Lupus

"This trial is testing a new drug called Gusacitinib in people with lupus, a disease where the immune system attacks healthy tissue. The study will involve participants aged 18 and older and will

Waitlist Available

No Cost For Treatment

National Institutes of Health Clinical CenterSarfaraz A Hasni, M.D.

Image of Memorial Sloan Kettering Basking Ridge (Consent Only) in Basking Ridge, United States.

Participants with high-grade glioma for Brain Tumor

Basking Ridge, NJ

This trial aims to determine if a type of imaging test called 68Ga-PSMA-11 PET/CT can accurately measure tumor activity in participants with high-grade glioma or brain metastases.

Memorial Sloan Kettering Basking Ridge (Consent Only) (+6 Sites)Simone Krebs, MD

Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.

Explore trials for Solu-Medrol

Image of Virginia Commonwealth University in Richmond, United States.

CALM +1 More for Brain Tumor

This trial is testing a therapy called CALM for people with brain cancer. It will compare CALM to the usual treatment that is currently used.

Virginia Commonwealth UniversityAshlee Loughan, Ph.D

Image of Children's Hospital Colorado in Aurora, United States.

Temozolomide +1 More for Astrocytoma

This trial will test if a drug can extend the life of kids/young adults with a deadly brain tumor linked to a genetic mutation.

Waitlist Available

Children's Hospital Colorado (+11 Sites)Maryam Fouladi, MDRigel Pharmaceuticals

Image of Arthritis & Osteoporosis Medical Center - La Palma ( Site 0108) in La Palma, United States.

MK-6194 for Lupus

This trial is testing a medication called MK-6194 to see if it is effective and safe for adults with Systemic Lupus Erythematosus. The main goal is to find out if

Senior-friendly

Arthritis & Osteoporosis Medical Center - La Palma ( Site 0108) (+7 Sites)Medical DirectorMerck Sharp & Dohme LLC

Image of University of California, Los Angeles (UCLA) Medical Center in Los Angeles, United States.

IMPT-514 for Lupus

Los Angeles, CA

This trial will study the safety and effectiveness of a new infusion therapy for those with lupus nephritis or SLE, followed up for 15 years.

University of California, Los Angeles (UCLA) Medical Center (+4 Sites)ImmPACT Bio

Have you considered Solu-Medrol clinical trials? We made a collection of clinical trials featuring Solu-Medrol, we think they might fit your search criteria.

Explore trials for Solu-Medrol

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security